Skip to content
BIO Events
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
Read More
Latest News
LATEST STORIES
Latest News
House advances legislation on PBM reform, orphan drug support, R&D deductions
Legislation to encourage rare disease drug development, enable tax deductions for research, and put checks on middlemen who drive up drug prices moved forward as ...
Agriculture
FDA approves pig genetically engineered to resist disease
The Food and Drug Administration (FDA) added to a small list of gene-edited animals that can be used in the food supply chain with its ...
Federal Policy
BIO’s comments on tariffs: There are better ways to strengthen U.S. biotech
Tariffs on pharmaceuticals would harm supply chains that ensure we have enough medicines while threatening America’s security, economy, and biotech leadership, the Biotechnology Innovation Organization ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
Read More
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor Conference ...
Read More